Dr. Yi Ding

Yi Ding, MD, PhDYi Ding, MD, PhD,
System and Core Laboratory Director of Molecular Diagnostics.

100 North Academy Avenue
Danville, PA 17822
1 800 695 6491

Dr. Ding is an associate of Geisinger Medical Laboratories at Danville, Pennsylvania, where she serves as the System and Core Laboratory Director of Molecular Diagnostics.

Education:

Dr. Ding received her MD from Beijing Medical University in Beijing, China, and her PhD at New York University School of Medicine.  She received pathology residency training at New York University Langone Medical Center, New York, New York, and completed fellowships in molecular genetic pathology at New York-Presbyterian Hospital, Weill Cornell Medical College, Cornell University, New York, New York, and in hematopathology at New York University Langone Medical Center, New York, New York.

Certifications:

Dr. Ding is board certified in both anatomic and clinical pathology, molecular genetic pathology, and hematology

Professional Affiliations:

Association for Molecular Pathology
New York State Society of Pathologists
College of American Pathologists
American Society for Clinical Pathology
United States and Canadian Academy of Pathology
Association of Chinese American Physician
Chinese American Pathologists Association
SIGMA Xi
American Association for the Advancement of Science
New York Academy of Sciences

Research Interests:

Hematopathology, molecular genetic pathology

Recent Academic Activity

Publications in Peer-Reviewed Journals:

Ding Y, Campbell A, Zhang X, Fu K, Yuan J. Metachronous and clonally related classic Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Pathology. 2020;2S0031-3025(20):30890-4.

Tsongalis GJ, Turkmani MRA, Suriawinata M, Babcock MJ, Mitchell K, Ding Y, Scicchitano L, Tira A, Buckingham L, Atkinson S, Lax A, Aisner AL, Davies KD, Wood HN, O’Neill SS, Levine EA, Sequeira J, Harada S, DeFrank G, Paluri R, Tan BA, Colabella H, Snead C, Cruz-Correa M, Ramirez V, Rojas A, Huang H, Mackinnon AC, Garcia FU, Cavone SM, Elfahal M, Abel G, Vasef MA, Judd A, Linder MW, Alkhateeb K, Skinner WL, Boccia R, Patel K. Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance between Standard of Care and the Biocartis Idylla™ Platform in Colorectal Cancer Patients. Am J Clin Pathol. 2020;154(2):266-276.

Wang W, Ding Y, Campbell A, Handy BC, Medeiros LJ, Lin P. Biclonal presentation of lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. Pathology. 2019;51(3):340-343.

Xu M, Pokrovskii M, Ding Y, Yi R, Au C, Harrison OJ, Galan C, Belkaid Y, Bonneau R, Littman DR. c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature. 2018;554(7692):373-377.

Ding Y, Miyamoto H, Rothberg PG. Is Tubulocystic Renal Cell Carcinoma Real?: Genomic Analysis Confirms the World Health Organization Classification. J Mol Diagn. 2018;20(1):28-30.

Reyes-Barron C, Burack WR, Rothberg PG, Ding Y. Next-Generation Sequencing for Minimal Residual Disease Surveillance in Acute Lymphoblastic Leukemia: An Update. Crit Rev Oncog. 2017;22(5-6):559-567.

Matsuzawa-Ishimoto Y, Shono Y, Gomez LE, Hubbard-Lucey VM, Cammer M, Neil J, Dewan MZ, Lieberman SR, Jay HV, Lazrak A, Liu C, Ding Y, van den Brink MRM, Cadwell K. Autophagy protein ATG16L1 prevents necroptosis in the intestinal epithelium.. J Exp Med . 2017;214(12):3687-3705.

Abstracts, Posters, and Other Presentations:

Lynn TJ, Ding Y, Alvi M, Zelonis MK, Monaco SE. Optimization of Thyroid Samples for Molecular Testing: Lessons learned from indeterminate thyroid fine needle aspirations with suboptimal cytology and molecular testing results. . Abstract and virtual poster United States and Canadian Academy of Pathology, Virtual meeting, March 2021.

Sarami I, Scicchitano L, Ding Y. Comparison of oncology biomarker testing turn-around time between standard of care method and a rapid testing platform. Abstract College of American Pathologists 2020 Annual Meeting, Las Vegas, Nevada, October 10-13, 2020.

Sarami I, Smelser DT, Cook AM, Haley JS, Vadakara JJ, Ding Y, Carey DY. A Population-Based Study Identifies Novel Variants for Myelodysplastic Syndrome Associated Genes. Abstract United States and Canadian Academy of Pathology, Los Angeles, California, February 29-March 5, 2020.

Scicchitano L, Brown A, Knock B, Prichard J, Ding Y. Practical Informatics Solutions for Molecular Diagnostics Quality Management.. Abstract Association for Molecular Pathology (AMP) 2019 Annual Meeting, Baltimore, Maryland, November 6-9, 2019.

Katerji H, Katerji R, Campbell A, Rothberg P, Ding Y. Clinical Utilization of Next Generation Sequencing based Clonality Assays for Immunoglobulin Heavy Chain in Evaluating Suspected B-cell Proliferation.. Abstract ASCP 2019 Annual Meeting, Phoenix, Arizona, September 11-13, 2019.

Reyes-Barron C, Ding Y. Detection of ERBB2 Copy Number Variants by Next Generation Sequencing and Comparison to Amplification Detection by Fluorescence in Situ Hybridization, Protein Quantitation Using Fluorescent Nanoparticles and Immunohistochemistry. Abstract USCAP 108th Annual Meeting,, National Harbor, Maryland,, March 16-21, 2019.

Campbell A, Crowe W, Spence J, Spence J, Rothberg P, Ding Y. Identification of FLT3 ITD using Next-Generation Sequencing (NGS): A single institution’s experience. Poster Association for Molecular Pathology (AMP) 2018, San Antonio, Texas, November 1-3, 2018.

Campbell A, Crowe W, Rothberg P, Ding Y.. Clinical Evaluation of the Archer VariantPlex Myeloid Panel for Mutation Profiling in Myeloid Neoplasms. Poster Association for Molecular Pathology (AMP) 2018, San Antonio, Texas, November 1-3, 2018.

Reyes-Barron C, Buscaglia B, Campbell A, Hicks D, Ding Y. Next Generation Sequencing for Quantitative Measurement of Human Epidermal Growth Factor Receptor-2 (HER2) Amplification: a Comparative Study. Poster Association for Molecular Pathology (AMP) 2018, San Antonio, Texas, November 1-3, 2018.

Reyes-Barron C, Campbell A, Rothberg P, Burack R, Ding Y. Next Generation Sequencing-Assays Detect B-Lymphocyte Clonality in Formalin-Fixed Paraffin Embedded Specimens of Classical Hodgkin Lymphoma without Microdissection. Poster Presentation USCAP 107th Annual Meeting, Vancouver, British Columbia, March 17-23, 2018.

Evans A, Ding Y, Laughlin T, Rothberg P, Casulo C, Burack R. IGH sequencing distinguishes multiple EBV+ Mucocutaneous ulcers (MCU) from recurrent malignant DLBCL. Platform Presentation Society of Hematopathology/European Association of Hematopathology Workshop meeting, Chicago, Illinois, September 7-9, 2017.

Crane GM, Rothberg P, Ding Y, Perkins AS, Liesveld JL, Burack R, and Evans AG. MDS/MonoMAC-like syndrome with multiple HPV-driven carcinomas arising in a patient with a novel germline GATA2 variant. Presentation Society of Hematopathology/European Association of Hematopathology Workshop meeting, Chicago, Illinois, September 7-9, 2017.

Ding Y, Crowe W, Spence J, Laughlin T, Spence J, Rothberg P, Burack WR. InDelDuper: a highly sensitive and specific algorithm for FLT3 ITD detection in next-generation. Platform Presentation USCAP 106th Annual Meeting, San Antonio, Texas, March 4-10, 2017.

Ding Y, Rothberg P, Laughlin T, Burack WR, and Evans AG. Multiple independent clonal origins of EBV+ lymphoproliferative disorders revealed by next generation deep sequencing of the immunoglobulin heavy chain (IGH) locus . Platform Presentation USCAP 106th Annual Meeting, San Antonio, Texas, March 4-10, 2017.

Textbook Chapters

Ding Y, Chen Z, Lin F. Overview of predictive biomarkers, and integration of immunohistochemistry into molecular pathology. In Handbook of Practical Immunohistochemistry-Frequently Asked Questions, 3rd Edition. Lin F, Prichard J, Liu H, Wilkerson M, eds. New York, New York: Springer, 2021: pp. In press.

Zhang M, Ding Y.. Lymph node. In Handbook of Practical Immunohistochemistry-Frequently Asked Questions, 3rd Edition. Lin F, Prichard J, Liu H, Wilkerson M, eds. New York, New York: Springer, 2021: pp. In press.

Yin H, Ding Y, Paynton B, Quinones W, Zelonis M, Snyder D, Kip, NS. In situ hybridization in surgical and cytologic specimens. In Handbook of Practical Immunohistochemistry-Frequently Asked Questions, 3rd Edition. Lin F, Prichard J, Liu H, Wilkerson M, eds. New York, New York: Springer, 2021: pp. -.

Locations  |    Search  |    Site Map |   Contact Us

©2000-2021 Geisinger Health System.   All rights reserved.